atc code v03 atc code v03 atc code v03 all other therapeutic products is a therapeutic subgroup of the anatomical therapeutic chemical classification system, a system of alphanumeric codes developed by the world health organization (who) for the classification of drugs and other medical products. subgroup v03 is part of the anatomical group v various. atc codes v various v01 allergens v03 all other therapeutic products v04 diagnostic agents v06 general nutrients v07 all other non-therapeutic products v08 contrast media v09 diagnostic radiopharmaceuticals v10 therapeutic radiopharmaceuticals v20 surgical dressings a b c d g h qi j l m n p r s v codes for veterinary use (atcvet codes) can be created by placing the letter q in front of the human atc code: for example, qv03. atcvet codes without corresponding human atc codes are cited with the leading q in the following list.national issues of the atc classification may include additional codes not present in this list, which follows the who version. v03a all other therapeutic products v03ab antidotes v03ab01 ipecacuanha v03ab02 nalorphine v03ab03 edetates v03ab04 pralidoxime v03ab05 prednisolone and promethazine v03ab06 thiosulfate v03ab08 sodium nitrite v03ab09 dimercaprol v03ab13 obidoxime v03ab14 protamine v03ab15 naloxone v03ab16 ethanol v03ab17 methylthioninium chloride v03ab18 potassium permanganate v03ab19 physostigmine v03ab20 copper sulfate v03ab21 potassium iodide v03ab22 amyl nitrite v03ab23 acetylcysteine v03ab24 digitalis antitoxin v03ab25 flumazenil v03ab26 methionine v03ab27 4-dimethylaminophenol v03ab29 cholinesterase v03ab31 prussian blue v03ab32 glutathione v03ab33 hydroxocobalamin v03ab34 fomepizole v03ab35 sugammadex v03ab36 phentolamine v03ab37 idarucizumab v03ab38 andexanet alfa qv03ab90 atipamezole qv03ab91 sarmazenil qv03ab92 diprenorfin qv03ab93 yohimbine qv03ab94 tolazoline qv03ab95 apomorphine qv03ab96 ropinirole v03ac iron chelating agents v03ac01 deferoxamine v03ac02 deferiprone v03ac03 deferasirox v03ae drugs for treatment of hyperkalemia and hyperphosphatemia v03ae01 polystyrene sulfonate v03ae02 sevelamer v03ae03 lanthanum carbonate v03ae04 calcium acetate and magnesium carbonate v03ae05 sucroferric oxyhydroxide v03ae06 colestilan v03ae07 calcium acetate v03ae08 ferric citrate v03ae09 patiromer calcium v03ae10 sodium zirconium cyclosilicate v03af detoxifying agents for antineoplastic treatment v03af01 mesna v03af02 dexrazoxane v03af03 calcium folinate v03af04 calcium levofolinate v03af05 amifostine v03af06 sodium folinate v03af07 rasburicase v03af08 palifermin v03af09 glucarpidase v03af10 sodium levofolinate v03af11 arginine and lysine v03af12 trilaciclib v03ag drugs for treatment of hypercalcemia v03ag01 sodium cellulose phosphate v03ag05 sodium phosphate v03ah drugs for treatment of hypoglycaemia v03ah01 diazoxide v03an medical gases v03an01 oxygen v03an02 carbon dioxide v03an03 helium v03an04 nitrogen v03an05 medical air v03ax other therapeutic products v03ax02 nalfurafine v03ax03 cobicistat v03ax04 difelikefalin v03az nerve depressants v03az01 ethanol